SIRT5: A safeguard against oxidative stress-induced apoptosis in cardiomyocytes

Cellular Physiology and Biochemistry

Volumn 32, Issue 4, 2013, Pages 1050-1059

  Liu, Ban ^a   Che, Wenliang ^a   Zheng, Changzhu ^b,c   Liu, Weijing ^a   Wen, Jing ^a   Fu, Haitao ^c   Tang, Kai ^a   Zhang, Jinying ^a   Xu, Yawei ^a  

^a TONGJI UNIVERSITY   (China)

^b Zhoupu Hospital of Pudong New Area   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Bcl Xl; Mitochondria; Oxidative stress; SIRT5

Indexed keywords

CASPASE 3; CASPASE 7; PROTEIN BCL XL; SIRTUIN 5; 3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 4',6 DIAMIDINO 2 PHENYLINDOLE; HYDROGEN PEROXIDE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IMMUNOPRECIPITATION; IN VITRO STUDY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; RAT; REPERFUSION INJURY; STAINING; WESTERN BLOTTING; WILD TYPE; APOPTOSIS ASSAY; CELL COUNT; ENZYME ACTIVITY; GENE SILENCING; MITOCHONDRION; MTT ASSAY; NEWBORN; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CASPASE 7; CELL LINE; CELL SURVIVAL; CELLS, CULTURED; HYDROGEN PEROXIDE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; SIRTUINS;

EID: 84886731779     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000354505     Document Type: Article

References (37)

1. Whelan RS, Kaplinskiy V, Kitsis RN: Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu Rev Physiol 2010;72:19-44
2. Van Amerongen MJ, Engel FB: Features of cardiomyocyte proliferation and its potential for cardiac regeneration. J Cell Mol Med 2008;12:2233-2244
3. Minamino T, Kitakaze M: ER stress in cardiovascular disease. J Mol Cell Cardiol 2010;48:1105-1110
4. Tsutsui H, Kinugawa S, Matsushima S: Mitochondrial oxidative stress and dysfunction in myocardial remodelling. Cardiovasc Res 2009;81:449-456
5. Roberts CK, Sindhu KK: Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712
6. Martindale JL, Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and surviva. J Cell Physiol 2002;192:1-15 (Pubitemid 34587382)
7. Finkel T, Deng CX, Mostoslavsky R: Recent progress in the biology and physiology of sirtuins. Nature 2009;460:587-591
8. Verdin E, Hirschey MD, Finley LWS, Haigis MC: Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 2010;35:669-675
9. Kim HS, Patel K, Muldoon-Jacobs K, Bisht KS, Aykin-Burns N, Pennington JD, van der Meer R, Nguyen P, Savage J, Owens KM: SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010;17:41-52
10. Haigis MC, Deng CX, Finley LWS, Kim HS, Gius D: SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the warburg effect, and carcinogenesis. Cancer Res 2012;72:2468-2472
11. Nakagawa T, Lomb DJ, Haigis MC, Guarente L: SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009;137:560-570
12. Ogura M, Nakamura Y, Tanaka D, Zhuang X, Fujita Y, Obara A, Hamasaki A, Hosokawa M, Inagaki N: Overexpression of SIRT5 confirms its involvement in deacetylation and activation of carbamoyl phosphate synthetase 1. Biochem Bioph Res Co 2010;393:73-78
13. Gomes LC, Di Benedetto G, Scorrano L: During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011;13:589-598
14. Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC: Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J 1999;18:5242-5251 (Pubitemid 29465575)
15. LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A: Tumor-cell resistance to death receptor-induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002;8:274-281 (Pubitemid 34250106)
16. Valks DM, Kemp TJ, Clerk A: Regulation of Bcl-xL expression by H2O2 in cardiac myocytes. J Biol Chem 2003;278:25542-25547 (Pubitemid 36835306)
17. Gottlieb E, Vander Heiden MG, Thompson CB: Bcl-XL prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol 2000;20:5680-5689 (Pubitemid 30482901)
18. Strassburger M, Bloch W, Sulyok S, Schller J, Keist AF, Schmidt A, Wenk J, Peters T, Wlaschek M, Krieg T: Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radical Biol Med 2005;38:1458-1470 (Pubitemid 40693831)
19. Wenzel P, Schuhmacher S, Kienhfer J, Mller J, Hortmann M, Oelze M, Schulz E, Treiber N, Kawamoto T, Scharffetter-Kochanek K: Manganese superoxide dismutase and aldehyde dehydrogenase deficiency increase mitochondrial oxidative stress and aggravate age-dependent vascular dysfunction. Cardiovasc Res 2008;80:280-289
20. Imai S, Guarente L: Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 2010;31:212-220
21. Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL: SIRT3 and cancer: tumor promoter or suppressor? BBA-Rev Cancer 2011;1816:80-88
22. Zhang Y, Zhou L: Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. Biochem Biophys Res Commun 2012;423:26-31
23. Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP: Mitochondrial SIRT3 and heart disease. Cardiovasc Res 2010;88:250-256
24. Baumann K: Cell death: a pro-Apoptotic role for sirtuin 3. Nat Rev Mol Cell Biol 2012;13:750
25. Schlicker C, Gertz M, Papatheodorou P, Kachholz B, Becker CFW, Steegborn C: Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008;382:790-801
26. Suenkel B, Fischer F, Steegborn C: Inhibition of the human deacylase Sirtuin 5 by the indole GW5074. Bioorg Med Chem Lett 2013;23:143-146
27. Trapp J, Jochum A, Meier R, Saunders L, Marshall B, Kunick C, Verdin E, Goekjian P, Sippl W, Jung M: Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. J Med Chem 2006;49:7307-7316 (Pubitemid 44913391)
28. Lackey K, Cory M, Davis R, Frye SV, Harris PA, Hunter RN, Jung DK, McDonald OB, McNutt RW, Peel MR, Rutkowske RD, Veal JM, Wood ER: The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 2000;10:223-226 (Pubitemid 30105376)
29. Chao DT, Linette GP, Boise LH, White LS, Thompson CB, Korsmeyer SJ: Bcl-XL and Bcl-2 repress a common pathway of cell death. J Exp Med 1995;182:821-828
30. Reeve JLV, Szegezdi E, Logue SE, Chonghaile TN, OBrien T, Ritter T, Samali A: Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-XL. J Cell Mol Med 2007;11:509-520 (Pubitemid 47153461)
31. Kirshenbaum LA, de Moissac D: The bcl-2 gene product prevents programmed cell death of ventricular myocytes. Circulation 1997;96:1580-1585 (Pubitemid 27375355)
32. Chen Z, Chua CC, Ho YS, Hamdy RC, Chua BHL: Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. Am J Physiol-Heart C 2001;280:H2313-H2320
33. Lee Y, Gustafsson B: Role of apoptosis in cardiovascular disease. Apoptosis 2009;14:536-548
34. Gill C, Mestril R, Samali A: Losing heart: the role of apoptosis in heart disease-A novel therapeutic target? FASEB J 2002;16:135-146 (Pubitemid 34113007)
35. Neubauer S: The failing heart-An engine out of fuel. N Engl J Med 2007;356:1140-1151 (Pubitemid 46425598)
36. Doenst T, Nguyen TD, Abel ED: Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 2013;113:709-724
37. Galindo CL, Skinner MA, Errami M, Olson LD, Watson DA, Li J, McCormick JF, McIver LJ, Kumar NM, Pham TQ, Garner HR: Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC Physiol 2009;9:23.